CD274 and diffuse large B-cell lymphoma: The study investigated PD-L1+CD20+ % and PD-1+CD20+ % with bone marrow involvement and B symptoms and identified that expression of PD-L1/PD-1 in CD20+ cells was increased in DLBCL patients with these clinical symptoms (Figure 3).